- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07642726
Change in Cognition and Frailty After Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus (iNPH)
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Idiopathic normal pressure hydrocephalus (iNPH) is characterized by one or more of the symptoms gait disturbance, cognitive decline and urinary incontinence. The pathophysiology is not fully understood, but disturbed cerebrospinal fluid (CSF) circulation is considered one of the contributing factors. The CSF disturbance can be treated by shunt surgery with significant improvement in gait velocity and balance, whereas improvements in cognitive function are more uncertain.
Frailty is a consequence of cumulative decline in many physiological systems during a lifetime and implies an increased vulnerability to poor resolution of homoeostasis after a stressor event. Frailty is emerging as an important risk factor for mortality and postoperative complications but has to a limited degree been studied in iNPH.
We have previously, in a cross-sectional design, described cognitive profile and frailty status in patients with iNPH accepted for shunt surgery at Oslo University Hospital. The aims of this longitudinal follow-up of the same patient cohort are twofold:
- to describe changes in cognitive profile and frailty from pre shunt to one year after the shunt surgery, and
- to identify clinical predictors of an improvement in terms of cognition and frailty during the same period.
The patient sample consists of 276 patients that were accepted for shunt surgery at Oslo University Hospital in the period from September 2018 to December 2023. Their mean age was 73.1 years (range 52-85), 61% were men, and their mean length of education was 12.5 years. For the cognitive tests, we utilised z-scores (number of standard deviations (SD) from the age and education adjusted mean in a normative dataset).
For frailty, we used a 35 items Frailty Index (FI). Most of the items (frailty indicators) are scored 0 (not present) or 1 (present), while some of them have a graded score. The index is the sum score divided by the number of items, varying from 0.0 (no frailty) to 1.0 (extreme frailty). We used the same approach for assessment of the degree of frailty within each frailty domain. Cognitive decline is considered as one component of frailty. Accordingly, the Mini Mental State Examination (MMSE) is part of the FI and has a graded score. MMSE sum score <21 gives a score of 1 at this particular FI item, an MMSE score of 21-23 gives an item score of 0.7, an MMSE score of 24-26 gives an item score of 0.3, whereas an MMSE score of 27-30 does not contribute to the FI. MMSE is a screening test covering several cognitive domains. We will use MMSE to evaluate the cognitive dimension of frailty as described here, whereas more specific cognitive tests are utilised to assess failure in particular cognitive domains.
Preoperatively, the mean FI score was 0.23, and the most common frailty markers were in the domains of physical function and instrumental activities of daily living (iADL). On the group level, the iNPH patients were impaired on all cognitive domains preoperatively, but compared to patients with Alzheimer's disease, they had relatively better-preserved memory and more severe impairments in phonemic fluency.
220 (80%) patients were assessed one year postoperatively. The same cognitive tests and frailty assessments were carried out, making it possible to calculate simple change scores as score(postop) - score(preop). We will compare baseline characteristics of patients lost to follow-up descriptively with those followed, to assess potential attrition bias.
A detailed Statistical Analysis Plan (SAP) describes the planned analytical approach.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
-
Oslo, Norvegia
- Department of Geriatric Medicine, Oslo University Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
• Diagnosed with iNPH and accepted for shunt surgery according to the American-European guidelines at Department of Neurosurgery, Oslo University Hospital, Rikshospitalet.
Exclusion Criteria:
- Non-native speakers of Norwegian
- Patients who had completed ≤ 3 cognitive tests
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Patients with idiopathic normal pressure hydrocephalus accepted for shunt surgery
|
Patients are already accepted for shunt surgery.
We will describe changes in cognitve profile and frailty from pre shunt to one year after to identify clinical predictors for shunt response.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Trail Making Test A (TMT A) from preoperative to postoperative in patients with idiopathic normal pressure hydrocephalus (iNPH).
Lasso di tempo: 12 month
|
TMT A is a cognitive test assessing attention and psychomotor speed and z-scores are calculated using age and educational adjusted norms.
The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean.
Higher z-score reflects better performance.
We have defined a Minimum Clinically Important Difference (MCID) as an increase in the z-score (number of standard deviations (SD)) from the age and education adjusted mean in a normative dataset of 0.5 or more for TMT A.
|
12 month
|
|
Change in Frailty Index (FI) from preoperative to postoperative in patients with idiopathic normal pressure hydrocephalus (iNPH).
Lasso di tempo: 12 months
|
For frailty, a 35 items FI was used.
Most of the items (frailty indicators) are scored 0 (not present) or 1 (present), while some of them have a graded score.
The index is the sum score divided by the numbers of items, varying from 0.0 (no frailty) to 1.0 (extreme frailty).
We have defined a Minimum Clinically Important Difference (MCID) as a decrease in the FI of 0.05 (5 %) or more.
|
12 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Other measures of cognition and frailty
Lasso di tempo: 12 months
|
Cognitive variables: For assessing memory, delayed word recall (z score from either Consortium to Establish a Registry for Alzheimer's disease (CERAD) ten words memory test or the Rey Auditory Learning Test were used. The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean. Higher z-score reflects better performance. MCID: Z-score difference 0.5. |
12 months
|
|
Other measures of cognition and frailty
Lasso di tempo: 12 months
|
Figure Construction Test from CERAD is a cognitive test assessing visuoconstructive abilities.
The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean.
Higher z-score reflects better performance.
MCID: Z-score difference 0.5.
|
12 months
|
|
Other measures of cognition and frailty
Lasso di tempo: 12 months
|
Trail Making Test B is a cognitive test assessing attention, psychomotor speed and executive function.
The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean.
Higher z-score reflects better performance.
MCID: Z-score difference 0.5.
|
12 months
|
|
Other measures of cognition and frailty
Lasso di tempo: 12 months
|
The Phonemic Fluency Test is a cognitive test assessing language abilities and executive function.
The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean.
Higher z-score reflects better performance.
MCID: Z-score difference 0.5.
|
12 months
|
|
Other measures of cognition and frailty
Lasso di tempo: 12 months
|
Mini Mental State Examination (MMSE-NR3) is a cognitive screening test from 0 - 30 covering several cognitive domains.
Higher score indicates better function.
MMSE is part of the FI and has a graded score.
MMSE sum score <21 gives a score of 1 at this particular FI item, an MMSE score of 21-23 gives an item score of 0.7, an MMSE score of 24-26 gives an item score of 0.3, whereas an MMSE score of 27-30 does not contribute to the FI.
MCID: 2 points.
|
12 months
|
|
Other measures of cognition and frailty
Lasso di tempo: 12 months
|
Personal activities in daily living (pADL) are subscales of the FI and are scored from 0-7, higher score indicates more need for help in daily living.
An improvement is set to at least 5 % for subscale as a limit for MCID.
|
12 months
|
|
Other measures of cognition and frailty
Lasso di tempo: 12 months
|
Instrumental activities in daily living (iADL) are subscales of the FI and are scored from 0-7, higher score indicates more need for help in daily living.
An improvement is set to at least 5 % for subscale as a limit for MCID.
|
12 months
|
|
Other measures of cognition and frailty
Lasso di tempo: 12 months
|
Gait speed (m/s) is measured from 10 m walk and 0.1 m/s or more is accepted as clinically meaningful.
MCID is set to 0.1 m/s.
|
12 months
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Responder analysis
Lasso di tempo: 12 months
|
Based on the MCID limits for each outcome, we will define a responder for each outcome as a patient improving that much or more from the preoperative to the one-year postoperative assessment and will calculate the percentage of responders for each of the outcomes. We will then analyse predictors for shunt response on each of the ten outcome variables. Candidate variables in the prediction models are: 1. Age. 2. Sex. 3. MMSE-NR3 score. 4. Gait speed. 5. FI score. 6. Difference in z-score between phonemic fluency and delayed recall at baseline. 7. Cluster affiliation (based on a previously published cluster analysis. The analytic strategy is described in detail in the Statistical Analysis Plan (SAP) that is uploaded as a separate document. |
12 months
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Malattie del cervello
- Malattie del sistema nervoso centrale
- Malattie del sistema nervoso
- Disordini mentali
- Processi patologici
- Disturbi neurocognitivi
- Disturbi cognitivi
- Condizioni patologiche, segni e sintomi
- Segni e sintomi
- Fragilità
- Disfunzione cognitiva
- Limitazione della mobilità
- Demenza
- Procedure chirurgiche, operative
- Procedure neurochirurgiche
- Anastomosi, chirurgica
- Shunt del liquido cerebrospinale
- Ventriculoperitoneal Shunt
Altri numeri di identificazione dello studio
- 10150 (formerly 2019/547)
- Funded by (Altro identificatore: Department of Geriatric Medicine Oslo University Hospital)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Criteri di accesso alla condivisione IPD
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Ventriculoperitoneal shunt
-
Second Affiliated Hospital, School of Medicine,...Westlake UniversityReclutamentoIdrocefalo idiopatico a pressione normaleCina
-
Imperial College LondonKing's College London; University College, London; Medical Research Council; University... e altri collaboratoriReclutamentoIdrocefalo a pressione normaleRegno Unito
-
CereVasc IncReclutamentoIdrocefalo a pressione normaleStati Uniti, Argentina, Canada
-
Kasr El Aini HospitalCompletato
-
Duke UniversityPediatric Hydrocephalus Foundation; Children's Miracle Network HospitalsCompletato
-
CAMC Health SystemCompletatoStenosi, arteria carotideaStati Uniti
-
NXT BiomedicalRitirato
-
University Hospital, LinkoepingAttivo, non reclutanteIdrocefalo, pressione normale | Ventricolomegalia, cerebrale | Shunt; Complicazioni | Idrocefalo acquisitoSvezia
-
Johan VirhammarSwedish Society for Medical ResearchReclutamentoIdrocefalo | Idrocefalo a pressione normaleSvezia, Finlandia, Italia
-
University Hospital, ToulouseReclutamentoDisturbo della coscienzaFrancia